SPET-generated colour-coded polar maps to quantify 99Tcm-MIBI and 123I-BMIPP uptake in chronically dysfunctional myocardium: Comparison with coronary anatomy and wall motion

Nuclear Medicine Communications

Volumn 18, Issue 12, 1997, Pages 1135-1147

  Hambye A S ^a   Dobbeleir, A ^a   Franken, P R ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; COLOR; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; FEMALE; HEART MOVEMENT; HUMAN; MALE; MYOCARDIAL DISEASE; REPRODUCIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031431763     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006231-199712000-00005     Document Type: Article

References (26)

1. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visiolo O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994; 23: 617-626.
2. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest/redistribution 201-Tl imaging in detection of myocardial viability and prediction of improvement of left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1630-1641.
3. Sawada SG, Allman KC, Muzik O et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994; 23: 92-98.
4. Altehoefer C, vom Dahl J, Biedermann M et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: Comparison with fluorine-18-FDG-PET. Eur J Nucl Med 1994; 35: 569-574.
5. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: Correlation with wall motion and inotropic reserve. J Nucl Med 1994; 35: 1758-1765.
6. Ito T, Tanouchi J, Kato J et al. Recovery of impaired left ventricular function in patients with acute myocardial infarction is predicted by the discordance in defect size on I123-BMIPP and 201Tl SPET images. Eur J Nucl Med 1996; 23: 917-923.
7. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996; 37: 718-722.
8. Tamaki N, Kawamoto M, Yonekura Y et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992; 33: 659-667.
9. Kawamoto M, Tamaki N, Yonekura Y et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: Comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994; 8: 47-54.
10. Mertens J, Eersels J, Van Ryckeghem W. New high yield Cu(I) assisted I-123 radioiodination of 15(p-I-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 1987; 13: 159-160.
11. Van Steelandt E, Dobbeleir A, Vanregemorter J. Compton scatter correction for scintigraphic imaging. In: Proceedings of the 11th Annual Symposium of the Belgian Association of Hospital Physicists, 1995: 23.
12. Hambÿe AS, Dobbeleir A, Stulens E, Vervaet A, Vandevivere J, Franken PR. 240°: Why not? Nucl Med Commun 1996; 17: 583-590.
13. Altman DG. Some common problems in medical research: Method comparison studies. In: Altman DG, ed. Practical statistics for medical research. London: Chapman & Hall, 1991: 396-403.
14. Iskandrian AS, Verani MS. Exercise perfusion imaging in coronary artery disease: Physiology and diagnosis. In: Nuclear cardiac imaging: Principles and applications, 2nd edn. Philadelphia, PA: F.A. Davis, 1996: 97.
15. Gioia G, Powers J, Hero J, Iskandrian AS. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 1995; 75: 759-762.
16. DiCarli MF, Davidson M, Little R et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
17. Gimple LW, Beller GA. Myocardial viability: Assessment by cardiac scintigraphy. Cardiol Clin 1994; 12: 317-332.
18. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1838.
19. Marzullo P, Sambuceti G, Parodi O et al. Regional concordance and discordance between thallium-201 and sestamibi imaging for assessing tissue viability: Comparison with post-revascularization functional recovery. J Nucl Cardiol 1995; 2: 309-316.
20. Chouraqui P, Maddahi J, Henkin R, Karesh SM, Galie E, Berman DS. Comparison of myocardial imaging with iodine-123-iodophenyl-9-methyl pentadecanoic acid and thallium-201-chloride for assessment of patients with exercise-induced myocardial ischemia. J Nucl Med 1991; 32: 447-452.
21. Kawamoto M, Tamaki N, Yonekura Y et al. Significance of myocardial uptake of iodine 123-labeled beta-methyl iodophenyl pentadecanoic acid: Comparison with kinetics of carbon 11-labeled palmitate in positron emission tomography. J Nucl Cardiol 1994; 1: 522-528.
22. Takeda K, Saito K, Makino K et al. Iodine-123-BMIPP myocardial washout during exercise in normal and ischemic hearts. J Nucl Med 1997; 38: 559-563.
23. Tamaki N, Tadamura E, Kudoh T et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue in patients with myocardial infarction. Eur J Nucl Med 1996; 23: 272-279.
24. Inubushi M, Kudoh T, Hattori N et al. I123-BMIPP/Tl-201 mismatching predicts wall motion recovery after CABG: Assessment with quantitative analysis. Ann Nucl Med 1996; 10: S79.
25. Taillefer R, Iskandrian A, Verani M et al. Observer variability in myocardial viability assessment with I123-IPPA: Results from the multicenter IPPA study. J Nucl Med 1996; 37: 184P.
26. Schad N, Wagner RK, Hallermeier J, Daus HJ, Vattimo A, Bertelli P. Regional rates of myocardial fatty acid metabolism: Comparison with coronary angiography and contrast ventriculography. Eur J Nucl Med 1990; 16: 205-212.